References
- Institute of MedicineRelieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and ResearchWashington, DCNational Academy of Sciences2011
- ManchikantiLFellowsBAilinaniHPampatiVTherapeutic use, abuse, and nonmedical use of opioids: a ten-year perspectivePain Physician201013540143520859312
- PaulozziLJJonesCMMackKARuddRAVital signs: overdoses of prescription opioid pain relievers – United States, 1999–2008MMWR Morb Mortal Wkly Rep201160431487149222048730
- VolkowNDMcLellanTACurtailing diversion and abuse of opioid analgesics without jeopardizing pain treatmentJAMA2011305131346134721467287
- Substance Abuse and Mental Health Services AdministrationDrug Abuse Warning Network, 2011: National Estimates of Drug-Related Emergency Department VisitsRockville, MDUS Department of Health and Human Services2013HHS Publication No (SMA) 13–4760, DAWN Series D-39
- National Center for Health StatisticsHealth, United States, 2012: With Special Feature on Emergency CareHyattsville, MDCDC2013
- ChouRFanciulloGJFinePGMiaskowskiCPassikSDPortenoyRKOpioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guidelineJ Pain200910213114619187890
- JonesTMooreTLevyJLA comparison of various risk screening methods in predicting discharge from opioid treatmentClin J Pain20122829310021750461
- MooreTMJonesTBrowderJHDaffronSPassikSDA comparison of common screening methods for predicting aberrant drug-related behavior among patients receiving opioids for chronic pain managementPain Med20091081426143320021601
- PassikSDKirshKLCasperDAddiction-related assessment tools and pain management: instruments for screening, treatment planning, and monitoring compliancePain Med20089Suppl 2S145S166
- WebsterLRWebsterRMPredicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk ToolPain Med20056643244216336480
- ButlerSFFernandezKBenoitCBudmanSHJamisonRNValidation of the revised screener and opioid assessment for patients with pain (SOAPP-R)J Pain20089436037218203666
- ButlerSFBudmanSHFanciulloGJJamisonRNCross validation of the current opioid misuse measure to monitor chronic pain patients on opioid therapyClin J Pain201026977077620842012
- ButlerSFBudmanSHFernandezKCDevelopment and validation of the current opioid misuse measurePain20071301–214415617493754
- IvesTJChelminskiPRHammett-StablerCAPredictors of opioid misuse in patients with chronic pain: a prospective cohort studyBMC Health Serv Res200664616595013
- BrownJSetnikBLeeKAssessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care settingJ Opioid Manag20117646748322320029
- SmithSMDartRCKatzNPAnalgesic, Anesthetic, and Addiction Clinical Trials, Translations, Innovations, Opportunities, and Networks (ACTTION) public-private partnership. Classification and definition of misuse, abuse, and related events in clinical trials: ACTTION systematic review and recommendationsPain2013154112287229623792283
- SetnikBRolandCLSommervilleKWAmulticenter, primary-care-based, open-label study to assess the success of converting opioid-experienced patients with chronic moderate-to-severe pain to morphine sulfate and naltrexone hydrochloride extended-release capsules using a standardized conversion guideJ Pain Res2015
- WeissmanDEHaddoxJDOpioid pseudoaddiction – an iatrogenic syndromePain19893633633662710565
- BeaudoinFLStraubeSLopezJMelloMJBairdJPrescription opioid misuse among ED patients discharged with opioidsAm J Emerg Med201432658058524726759
- HanHKassPHWilseyBLLiCSIncreasing trends in Schedule II opioid use and doctor shopping during 1999–2007 in CaliforniaPharmacoepidemiol Drug Saf2014231263523956137
- BaumblattJAWiedemanCDunnJRSchaffnerWPaulozziLJJonesTFHigh-risk use by patients prescribed opioids for pain and its role in overdose deathsJAMA Intern Med2014174579680124589873
- MansbachRSSchoedelKAKittrelleJPSellersEMThe role of adverse events and related safety data in the pre-market evaluation of drug abuse potentialDrug Alcohol Depend2010112317317720817417